Impact of COVID-19 on global HCV elimination efforts.
Blach S, et al. J Hepatol. 2021;74(1):31-36.
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.
Chappell CA, et al. Lancet Microbe. 2020;1:e200-208.
Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy.
Kushner T, Reau N. J Hepatol. 2021;74(3):734-741.
Development of an interdisciplinary telehealth model of provider training and comprehensive care for hepatitis C and opioid use disorder in a high-burden region.
Sherbuk JE, et al. J Infect Dis. 2020;222(Suppl 5):S354-S364.
The impact of COVID-19 on vulnerable populations and implications for children and health care policy.
Siegal RM, Mallow PJ. Clin Pediatr (Phila). 2020;60(2):93-98.
Minimal monitoring of treatment for hepatitis C virus infection.
Sulkowski M. Gastroenterol Hepatol. 2020;17(5):230-232.
A framework for patient-centered telemedicine: application and lessons learned from vulnerable populations.
Talal AH, et al. J Biomed Inform. 2020;112:103622
SARS-CoV-2 infection and the liver.
Morgan K, et al. Pathogens. 2020;9(6):430.
Clinical Practice Guidelines
CDC Recommendations for Hepatitis C Screening Among Adults in the United States.
Centers for Disease Control and Prevention (CDC). Last reviewed July 2020.
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
American Association for the Study of Liver Diseases (AASLD). March 2021.
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases (AASLD/Infectious Diseases Society of America (IDSA), Last updated March 2021.
Simplified HCV Treatment Algorithm for Treatment-Naive Adults Without Cirrhosis.
American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA). Last updated August 2020.
Clinical Resources
Hepatitis C Online Tools and Calculators: APRI
Hepatitis C Online: University of Washington.
Hepatitis C Online Tools and Calculators: FIB-4
Hepatitis C Online: University of Washington.
HEP Drug Interactions
University of Liverpool.
National Harm Reduction Coalition
Action and Advocacy: National HCV Resources
Center for Health Law and Policy Innovation (CHLPI)
CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.
Hepatitis Education Project (HEP)
HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.
National Viral Hepatitis Roundtable
National Viral Hepatitis Roundtable (NVHR) is a coalition working together to eliminate hepatitis B and C in the U.S. It offers practical online resources for practice management.
Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map
SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.
Patient Resources
Hepatitis C Information Center
American Liver Foundation.
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created to support individuals impacted by HCV infection.
Hepatitis C Questions and Answers for the Public
Centers for Disease Control and Prevention (CDC). Last reviewed July 2020.
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
Treating Hepatitis C in Primary Care? You Can! You Should!
Module 1
Faculty: | Ricardo Franco, MD; Charles P. Vega, MD, FAAFP |
Release: | 09/20/2021 |
Expiration: | 09/20/2022 |
The Dual Realities of the Opioid Epidemic and Rising Maternal HCV Rates: What the OB/GYN Needs to Know!
Module 2
Faculty: | Ricardo Franco, MD; Catherine A. Chappell, MD MSc |
Release: | 09/30/2021 |
Expiration: | 09/30/2022 |
The Impact of the COVID-19 Pandemic on Vulnerable Populations
Module 3
Faculty: | Ricardo Franco, MD; David L. Wyles, MD |
Release: | 09/30/2021 |
Expiration: | 09/30/2022 |